Alterity Therapeutics
ATHE
10 hedge funds and large institutions have $1.27M invested in Alterity Therapeutics in 2020 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 6 closing their positions.
103% more capital invested
Capital invested by funds: $623K → $1.27M (+$642K)
0% more ownership
Funds ownership: 0.01% → 0.01% (+0%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
29% less funds holding
Funds holding: 14 → 10 (-4)
67% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$330K |
| 2 |
Morgan Stanley
New York
|
+$41.7K |
| 3 |
GWM
Geneos Wealth Management
Englewood,
Colorado
|
+$6.45K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$108K |
| 2 |
EP
Eudaimonia Partners
Winchester,
Tennessee
|
-$30K |
| 3 |
FIA
FNY Investment Advisers
New York
|
-$4K |
| 4 |
CAN
Cetera Advisor Networks
El Segundo,
California
|
-$1K |
| 5 |
OIA
Optimum Investment Advisors
Chicago,
Illinois
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Morgan Stanley
New York
| $901K | +$41.7K | +2,048 | +5% |
|
|
2
Renaissance Technologies
New York
| $328K | +$330K | +16,222 | New |
|
3
Geode Capital Management
Boston,
Massachusetts
| $24K | – | – | – |
|
|
GWM
4
Geneos Wealth Management
Englewood,
Colorado
| $6K | +$6.45K | +317 | New |
|
5
Wells Fargo
San Francisco,
California
| $5K | – | – | – |
|
|
SWM
6
Sugarloaf Wealth Management
Duluth,
Georgia
| $1K | – | – | – |
|
|
APA
7
American Portfolios Advisors
Holbrook,
New York
| $168 | – | – | – |
|
|
8
UBS Group
Zurich,
Switzerland
| – | -$108K | -5,287 | -100% |
|
|
EP
9
Eudaimonia Partners
Winchester,
Tennessee
| – | -$30K | -2,500 | Closed |
|
|
FIA
10
FNY Investment Advisers
New York
| – | -$4K | -385 | Closed |
|
|
CAN
11
Cetera Advisor Networks
El Segundo,
California
| – | -$1K | -120 | Closed |
|
|
OIA
12
Optimum Investment Advisors
Chicago,
Illinois
| – | -$1K | -100 | Closed |
|
|
PAG
13
Private Advisor Group
Morristown,
New Jersey
| – | -$1K | -45 | Closed |
|
ATHE Hedge Fund Activity: Q3 2020 in Review
10 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Alterity Therapeutics (ATHE) for Q3 2020, worth a combined $1.27M — up 103% from $623K a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of ATHE and 2 opened new positions — a net loss of 4 holders — while 1 trimmed existing stakes and 1 added.
The largest buyer was Renaissance Technologies, opening a new position worth an estimated $330K. The largest seller was UBS Group, cutting an estimated $108K.
- 10 institutional investors held Alterity Therapeutics (ATHE) as of Q3 2020, down from 14 in Q2 2020.
- Funds reported $1.27M of Alterity Therapeutics stock for Q3 2020, up 103% quarter-over-quarter.
- 2 funds opened new Alterity Therapeutics positions in Q3 2020 and 6 closed out, a net change of -4 holders.
- The largest Alterity Therapeutics buyer in Q3 2020 was Renaissance Technologies, an estimated $330K added.
- The largest Alterity Therapeutics seller in Q3 2020 was UBS Group, an estimated $108K sold.
Based on aggregated 13F filings for Q3 2020.